# vTv Therapeutics Inc.: filings

VTVT · Nasdaq · CIK 1641489 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vtvt.md) · [Financials](/companies/vtvt/financials.md) · [Filings](/companies/vtvt/filings.md) · [Insiders](/companies/vtvt/insiders.md)

## Reports and events: 291 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 173, 4 170, SC 13D/A 45, 10-Q 34, 3 33, CORRESP 13, UPLOAD 13, 10-K 11, DEF 14A 11, DEFA14A 8, EFFECT 8, D 7, 424B5 6, CT ORDER 6, S-1/A 6, S-3 6, S-8 4, SC 13D 4, SCHEDULE 13G/A 4, 144 3, 424B2 3, SCHEDULE 13D/A 3, SCHEDULE 13G 3, 10-K/A 2, 424B3 2, FWP 2, S-1 2, SC 13G 2, 424B4 1, 4/A 1, 8-A12B 1, CERTNAS 1, DEF 14C 1, DRS 1, DRSLTR 1, PRE 14A 1, PRE 14C 1, S-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 20:31 ET | [8-K](/filings/0001641489-26-000032.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641489-26-000032 |
| 2026-08-06 | 20:24 ET | [10-Q](/filings/0001641489-26-000030.md) | Quarterly report, period 2026-06-30 | 0001641489-26-000030 |
| 2026-08-06 | 20:18 ET | [8-K](/filings/0001641489-26-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-26-000029 |
| 2026-06-29 | 20:14 ET | [8-K](/filings/0001641489-26-000024.md) | 5.07 Shareholder vote results | 0001641489-26-000024 |
| 2026-05-13 | 21:20 ET | [8-K](/filings/0001193125-26-221971.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-221971 |
| 2026-05-13 | 20:21 ET | [10-Q](/filings/0001641489-26-000020.md) | Quarterly report, period 2026-03-31 | 0001641489-26-000020 |
| 2026-05-13 | 20:18 ET | [8-K](/filings/0001641489-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-26-000019 |
| 2026-04-28 | 20:21 ET | [DEF 14A](/filings/0001641489-26-000015.md) | Proxy statement, period 2026-06-10 | 0001641489-26-000015 |
| 2026-03-10 | 20:37 ET | [8-K](/filings/0001641489-26-000012.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641489-26-000012 |
| 2026-03-10 | 20:35 ET | [8-K](/filings/0001641489-26-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-26-000011 |
| 2026-03-10 | 20:32 ET | [10-K](/filings/0001641489-26-000010.md) | Annual report, period 2025-12-31 | 0001641489-26-000010 |
| 2026-02-26 | 12:51 ET | [8-K](/filings/0001641489-26-000005.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641489-26-000005 |
| 2026-02-02 | 21:18 ET | [8-K](/filings/0001641489-26-000002.md) | 1.01 Entry into a material agreement | 0001641489-26-000002 |
| 2025-12-19 | 22:10 ET | [8-K](/filings/0001641489-25-000066.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641489-25-000066 |
| 2025-12-09 | 21:17 ET | [SCHEDULE 13D/A](/filings/0001699737-25-000029.md) | Ownership report, active investor, amended | 0001699737-25-000029 |
| 2025-11-06 | 21:32 ET | [10-Q](/filings/0001641489-25-000060.md) | Quarterly report, period 2025-09-30 | 0001641489-25-000060 |
| 2025-11-06 | 21:26 ET | [8-K](/filings/0001641489-25-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-25-000058 |
| 2025-09-25 | 21:06 ET | [SCHEDULE 13D/A](/filings/0001699737-25-000004.md) | Ownership report, active investor, amended | 0001699737-25-000004 |
| 2025-09-10 | 17:03 ET | [8-K](/filings/0001641489-25-000055.md) | 7.01 Regulation FD disclosure | 0001641489-25-000055 |
| 2025-09-03 | 23:33 ET | [SCHEDULE 13D/A](/filings/0001415889-25-023605.md) | Ownership report, active investor, amended | 0001415889-25-023605 |
| 2025-09-02 | 13:00 ET | [8-K](/filings/0001193125-25-193486.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-193486 |
| 2025-08-12 | 20:09 ET | [10-Q](/filings/0001641489-25-000053.md) | Quarterly report, period 2025-06-30 | 0001641489-25-000053 |
| 2025-08-12 | 20:05 ET | [8-K](/filings/0001641489-25-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-25-000051 |
| 2025-06-12 | 20:23 ET | [8-K](/filings/0001641489-25-000038.md) | 5.07 Shareholder vote results | 0001641489-25-000038 |
| 2025-05-19 | 20:24 ET | [8-K](/filings/0001641489-25-000032.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641489-25-000032 |
| 2025-05-16 | 13:05 ET | [8-K](/filings/0001641489-25-000030.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641489-25-000030 |
| 2025-05-15 | 20:11 ET | [8-K](/filings/0001641489-25-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-25-000028 |
| 2025-05-15 | 20:07 ET | [10-Q](/filings/0001641489-25-000026.md) | Quarterly report, period 2025-03-31 | 0001641489-25-000026 |
| 2025-04-25 | 20:20 ET | [DEF 14A](/filings/0001641489-25-000024.md) | Proxy statement, period 2025-06-10 | 0001641489-25-000024 |
| 2025-04-11 | 20:25 ET | [8-K](/filings/0001641489-25-000018.md) | 5.02 Departure or appointment of officers or directors | 0001641489-25-000018 |
| 2025-03-31 | 20:30 ET | [8-K](/filings/0001641489-25-000016.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641489-25-000016 |
| 2025-03-20 | 20:28 ET | [10-K](/filings/0001641489-25-000014.md) | Annual report, period 2024-12-31 | 0001641489-25-000014 |
| 2025-03-20 | 20:27 ET | [8-K](/filings/0001641489-25-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-25-000013 |
| 2025-03-17 | 13:03 ET | [8-K](/filings/0001641489-25-000010.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641489-25-000010 |
| 2025-02-27 | 21:14 ET | [8-K](/filings/0001641489-25-000005.md) | 5.02 Departure or appointment of officers or directors | 0001641489-25-000005 |
| 2025-01-13 | 13:33 ET | [8-K](/filings/0001641489-25-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641489-25-000003 |
| 2024-11-12 | 21:43 ET | [10-Q](/filings/0001641489-24-000075.md) | Quarterly report, period 2024-09-30 | 0001641489-24-000075 |
| 2024-11-12 | 21:26 ET | [8-K](/filings/0001641489-24-000073.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-24-000073 |
| 2024-10-25 | 20:29 ET | [8-K](/filings/0001641489-24-000069.md) | 1.02 Termination of a material agreement | 0001641489-24-000069 |
| 2024-08-08 | 20:27 ET | [8-K](/filings/0001641489-24-000063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-24-000063 |
| 2024-08-08 | 20:20 ET | [10-Q](/filings/0001641489-24-000061.md) | Quarterly report, period 2024-06-30 | 0001641489-24-000061 |
| 2024-07-26 | 20:17 ET | [8-K](/filings/0001641489-24-000057.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641489-24-000057 |
| 2024-07-02 | 20:41 ET | [8-K](/filings/0001641489-24-000054.md) | 1.01 Entry into a material agreement | 0001641489-24-000054 |
| 2024-06-14 | 20:22 ET | [8-K](/filings/0001641489-24-000045.md) | 5.07 Shareholder vote results | 0001641489-24-000045 |
| 2024-05-09 | 20:32 ET | [10-Q](/filings/0001641489-24-000029.md) | Quarterly report, period 2024-03-31 | 0001641489-24-000029 |
| 2024-05-09 | 20:28 ET | [8-K](/filings/0001641489-24-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-24-000027 |
| 2024-04-25 | 20:23 ET | [DEF 14A](/filings/0001641489-24-000023.md) | Proxy statement, period 2024-06-11 | 0001641489-24-000023 |
| 2024-03-26 | 20:35 ET | [8-K](/filings/0001641489-24-000020.md) | 8.01 Other events | 0001641489-24-000020 |
| 2024-03-22 | 20:57 ET | [SC 13D/A](/filings/0000950142-24-000754.md) | Ownership report, active investor, amended | 0000950142-24-000754 |
| 2024-03-14 | 11:57 ET | [8-K](/filings/0001641489-24-000014.md) | 5.02 Departure or appointment of officers or directors | 0001641489-24-000014 |

Page 1 of 6. [Older](/companies/vtvt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.